Frequency Therapeutics Inc (KRRO) Stock Analysis

Frequency Therapeutics Inc (KRRO) is a publicly traded company in the HEALTHCARE sector. It trades at $11.00, carries a market capitalization of $186.48M. This page summarizes the public market data, fundamentals, and frequently asked questions for KRRO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Frequency Therapeutics Inc currently has a Neutral sentiment score of 0.10.

About Frequency Therapeutics Inc

Korro Bio, Inc. is a forward-looking biopharmaceutical company based in Cambridge, Massachusetts, specializing in RNA editing technologies to develop genetic medicines aimed at treating both rare and common diseases. By harnessing innovative science, the company is advancing a diverse pipeline of transformative therapies that seek to address significant unmet medical needs and reshape treatment paradigms across various therapeutic domains. With its strong commitment to delivering breakthrough...

GNG Research Analysis

GNG Research scores Frequency Therapeutics Inc (KRRO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KRRO.

Frequently Asked Questions

Does KRRO pay dividends?

Frequency Therapeutics Inc (KRRO) does not currently pay a regular dividend.

What is KRRO's market cap?

Frequency Therapeutics Inc (KRRO) has a market capitalization of $186.48M with a current stock price of $11.00.